Article History
First Online: 1 September 2018
Compliance with Ethical Standards
:
: No sources of funding were used to assist in the preparation of this article.
: Susan Bates has been a principal investigator for romidepsin and belinostat studies, and received research funding from Celgene, Inc. She has also participated in advisory boards for Celgene and Mundipharma, and received honoraria for participating in these advisory boards. Larisa Geskin and Adriana Lopez have no conflicts of interest to declare.